In 2005, Chris Hansen, a lawyer at the ACLU, heard that a biotech company called Myriad Genetics had identified a gene responsible for most types of inherited breast and ovarian cancer... and then patented it.
With its patent, Myriad could effectively block anyone else from doing comprehensive testing or in some cases even doing research on the gene. And Chris thought that this was definitely not okay.
Today on the show, the story of the rise and fall of gene patents, and how the Supreme Court answered the question: Who do your genes belong to? It's Big Biotech versus the right to the information encoded in our very DNA, and how that fight went all the way to the Supreme Court. Come for the deoxyribonucleic acid — stay for the chocolate chip cookies and baseball bats.
Music: "Smoke and Mirrors," "Cosmic Cowboy," and "Jamrock We A Come From."
Find us: Twitter / Facebook / Instagram / TikTok
Subscribe to our show on Apple Podcasts, Pocket Casts and NPR One.
You know what's a patently good idea? Subscribing to our Newsletter.
"all" - Google News
November 21, 2020 at 08:37AM
https://ift.tt/2UII2Fb
The fight to patent genes goes all the way to the Supreme Court : Planet Money - NPR
"all" - Google News
https://ift.tt/2vcMBhz
Bagikan Berita Ini
0 Response to "The fight to patent genes goes all the way to the Supreme Court : Planet Money - NPR"
Post a Comment